Gen-Probe Posts 6 Percent Revenue Growth for Q1

A 15 percent increase in clinical diagnostics sales offset a 6 percent decline in the firm's blood screening business and a 25 percent drop in research products and services.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.